Transhepatic Access for Mitral Valve Replacement
Transhepatic access is a feasible alternative for transcatheter, transseptal procedures in patients with IVC interruption; however, special care must be taken to guarantee proper access for hemostasis. Hemorrhagic complications remain a concern in patients who undergo mitral ViV procedures owing to the need for anticoagulation therapy.
Authors
- Lucas Ferreira Marcondes Lemos (ORCID: https://orcid.org/0000-0003-4167-9163)
- Ibraim Pinto (ORCID: https://orcid.org/0000-0002-0886-0844)
- Andréa de Andrade Vilela (ORCID: https://orcid.org/0000-0003-0056-4378)
- Dimytri Siqueira (ORCID: https://orcid.org/0000-0003-4903-5274)
- Auristela Isabel de Oliveira Ramos (ORCID: https://orcid.org/0000-0001-7180-5779)
- Alberto Colella Cervone (ORCID: https://orcid.org/0000-0001-6887-1169)
- Fausto Feres (ORCID: https://orcid.org/0000-0003-1754-8876)
- Matheus Ornelas de Souza
- Dorival Júlio Della Togna
- Carlos Augusto Cardoso Pedra (ORCID: https://orcid.org/0009-0004-7014-690X)
Institutions
- Instituto Dante Pazzanese de Cardiologia (BR)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106122
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00